Interleukin-3
- Name
- Interleukin-3
- Accession Number
- DBCAT004898
- Description
Not Available
- Drugs
Drug Drug Description Muplestim Muplestim is under investigation in clinical trial NCT00002258 (A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in... - Drugs & Drug Targets
Drug Target Type